Publications by authors named "Pierre Bet"

Claim this Profile
S
Stable remission of depression after antidepressant treatment: prevalence and related sociodemographic and clinical characteristics in a longitudinal, real-world cohort.
Mariska Bot, Suzanne A Ligthart, Huibert Burger, Nina H Grootendorst-van Mil, Ingrid A Arnold, Pierre M Bet

J Affect Disord· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to: Dihydropyrimidine Dehydrogenase Enzyme-Guided Dosing of 5-Fluorouracil: Prioritizing Precision Over Dose Reduction.
Helle-Brit Fiebrich-Westra, Christina Haroun, Remco van der Galiën, Daphne den Besten-Bertholee, Maarten J Deenen, Pierre M Bet

JCO Precis Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Barriers, facilitators, and implementation strategies for pharmacogenomics in community pharmacies: a cross-sectional survey among local champions in pharmacies and key opinion leaders in pharmacogenomics.
Pantea Kiani, Pierre M Bet, Naomi T Jessurun, Petra Hoogland, Jeroen Mentink

Int J Clin Pharm· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of low-dose amitriptyline and mirtazapine in patients with insomnia disorder and sleep maintenance problems: a randomised, double-blind, placebo-controlled trial in general practice (DREAMING).
Mette H Bakker, Jacqueline G Hugtenburg, Pierre M Bet, Jos Wr Twisk, Henriëtte E van der Horst

Br J Gen Pract· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sodium Oxybate as a Potential New Treatment for Catatonia in Patients With Depression, Bipolar Disorder, or a Psychotic Disorder: Protocol for a Randomized Controlled Trial.
Lilian Bot, Josine G van Mill, Laetitia J C A Smarius, Adriaan W Hoogendoorn, Bram W C Storosum, Pierre M Bet

JMIR Res Protoc· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Barriers and facilitators for implementing a pharmacogenetic passport: lessons learned from reusing sequencing data.
Anja H A Roelofsen, Loes Lindiwe Kreeftenberg, Carla G van El, Lidewij Henneman, Tessel Rigter, Pierre M Bet

Pharmacogenomics· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Healthcare Providers' Perspectives on Antidepressant Discontinuation: A Focus Group Study.
S Bouarfa, Wilma Göttgens, Suzanne A Ligthart, Otto R Maarsingh, Christiaan H Vinkers, Pierre M Bet

Basic Clin Pharmacol Toxicol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Precision Treatment of Patients With GI Cancer Using Pre-emptive Genotyping/Phenotyping Plus Pharmacokinetic-Guided Dosing of 5-Fluorouracil.
Helle-Brit Fiebrich-Westra, Christina Haroun, Remco van der Galiën, Daphne den Besten-Bertholee, Maarten J Deenen, Pierre M Bet

JCO Precis Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Placebo-related improvement with methylphenidate treatment in children with ADHD.
Karen Vertessen, Jaap Oosterlaan, Pierre Bet, Marco Bottelier, Reino Stoffelsen

Eur Child Adolesc Psychiatry· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatic Safety Considerations in the Use of Ulipristal Acetate for Symptomatic Uterine Fibroids.
Annika Semmler, Maria E de Lange, Joost P H Drenth, Niels S Vermeer, Pierre M Bet

Ther Clin Risk Manag· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thymine as potential biomarker to predict 5-FU systemic exposure in patients with gastro-intestinal cancer: a prospective pharmacokinetic study (FUUT-trial).
Maarten A Hanrath, Evi Banken, Sebastian A H van den Wildenberg, Daan van de Kerkhof, Dirk Jan A R Moes, Pierre M Bet

Cancer Chemother Pharmacol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving Methylphenidate Titration in Children with Attention-Deficit/Hyperactivity Disorder (ADHD): A Randomized Controlled Trial Using Placebo-Controlled Titration Implemented in Clinical Practice.
Karen Vertessen, Marjolein Luman, Pierre Bet, Catharina E Bergwerff, Marco Bottelier

Paediatr Drugs· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacotherapy to Improve Cognitive Functioning After Acquired Brain Injury: A Meta-Analysis and Meta-Regression.
Ruud van der Veen, Marsh Königs, Simon Bakker, Andries van Iperen, Saskia Peerdeman, Pierre M Bet

Clin Pharmacol Ther· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of CYP2D6 and CYP2C19 metabolizer status with switching and discontinuing antidepressant drugs: an exploratory study.
Jurriaan M J L Brouwer, Klaas J Wardenaar, Ilja M Nolte, Edith J Liemburg, Pierre M Bet

BMC Psychiatry· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Three Prospective Case Studies Examining Mifepristone's Efficacy in Patients with Treatment-Resistant PTSD.
Agnes van Minnen, Lizelotte Vos, Pierre M Bet, Ad de Jongh, Felix Linsen

Case Rep Psychiatry· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Methylphenidate dose-response in children with ADHD: evidence from a double-blind, randomized placebo-controlled titration trial.
Karen Vertessen, Marjolein Luman, James M Swanson, Marco Bottelier, Reino Stoffelsen, Pierre Bet

Eur Child Adolesc Psychiatry· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Considerations on implementation of the newest treatment for symptomatic uterine fibroids: Oral GnRH antagonists.
Maria E de Lange, Annika Semmler, T Justin Clark, Ben Willem J Mol, Pierre M Bet

Br J Clin Pharmacol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of intravenous imatinib in COVID-19 ARDS: a randomized, double-blind, placebo-controlled clinical trial.
Leila N Atmowihardjo, Job R Schippers, Erik Duijvelaar, Imke H Bartelink, Pierre M Bet

Crit Care· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and pharmacodynamics of imatinib for optimal drug repurposing from cancer to COVID-19.
Nadia Baalbaki, Erik Duijvelaar, Medhat M Said, Job Schippers, Pierre M Bet

Eur J Pharm Sci· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimation of glomerular filtration rate for drug dosing in patients with very high or low body mass index.
Erik M Donker, Pierre Bet, Azam Nurmohamed, Erik Serné, George Louis Burchell

Clin Transl Sci· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vitamin D supplementation in chronic obstructive pulmonary disease patients with low serum vitamin D: a randomized controlled trial.
Rachida Rafiq, Floor E Aleva, Jasmijn A Schrumpf, Johannes M Daniels, Pierre M Bet

Am J Clin Nutr· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementation of a pharmacist-led transitional pharmaceutical care programme: Process evaluation of Medication Actions to Reduce hospital admissions through a collaboration between Community and Hospital pharmacists (MARCH).
Selma En-Nasery-de Heer, Elien B Uitvlugt, Pierre M Bet, Bart J F van den Bemt, Aida Alai

J Clin Pharm Ther· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rivastigmine for ECT-induced cognitive adverse effects in late life depression (RECALL study): A multicenter, randomized, double blind, placebo-controlled, cross-over trial in patients with depression aged 55 years or older: Rationale, objectives and methods.
Marieke J Henstra, Thomas C Feenstra, Rob M Kok, Harm-Pieter Spaans, Eric van Exel, Pierre M Bet

Front Psychiatry· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of marketing authorization and clinical implementation of ulipristal acetate for uterine fibroids.
Mei-An Middelkoop, Maria E de Lange, T Justin Clark, Ben Willem J Mol, Pierre M Bet

Hum Reprod· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The INVENT COVID trial: a structured protocol for a randomized controlled trial investigating the efficacy and safety of intravenous imatinib mesylate (Impentri®) in subjects with acute respiratory distress syndrome induced by COVID-19.
Leila Atmowihardjo, Job R Schippers, Imke H Bartelink, Pierre M Bet, Nienke van Rein

Trials· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis